Troluce Capital Advisors »

Tscan Therapeutics shares owned by Troluce Capital Advisors

Quarter-by-quarter ownership of Tscan Therapeutics (TCRX) shares owned by Troluce Capital Advisors from 13F filings

Historical chart of Troluce Capital Advisors investment in Tscan Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tscan Therapeutics held by Troluce Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tscan Therapeutics by Troluce Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-06-30 $218k 150k 1.45
2025-03-31 $116k 84k 1.38
2024-12-31 $161k 53k 3.04
2024-09-30 $264k 53k 4.98
2024-06-30 $543k 93k 5.85